OTX1 along with TWIST1 and ONECUT2 examined by SNaPshotTM methylation analysis exhibited SN/SP of 97%/83% and AUC 0.92 for BC prediction in hematuria patients [102]. This evidence concerns the gene OTX1 and breast cancer.